Robert B. Huizinga - Concepedia

Author

Robert B. Huizinga

Also Known As

Huizinga, Robert B., R B. Huizinga, R Huizinga, R. Huizinga, R.B. Huizinga, RB Huizinga, Robert B Huizinga, Robert B. Huizinga, Robert Huizinga

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Aurinia (Canada)St. Luke's Medical Center University of Louisville Oklahoma Medical Research Foundation The Ohio State University Wexner Medical Center

About

Robert B. Huizinga is an author at Aurinia (Canada) specializing in medicine, immunology, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1K
2	Health Sciences	1	1	33
3	Cell Biology	1	1	33
4	Diabetes	1	1	33
5	Endocrinology	1	1	33

Robert B. Huizinga

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Brad H. Rovin, Y K Onno Teng, Ellen M. Ginzler, The Lancet GlomerulonephritisAutoimmune DiseaseVoclosporin Versus PlaceboSystemic Lupus Erythematosus TreatmentLupus	2021	534
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis Brad H. Rovin, Neil Solomons, William F. Pendergraft, Kidney International Dose-ranging VoclosporinGlomerulonephritisAutoimmune DiseaseSystemic Lupus Erythematosus TreatmentLupus	2018	290
Safety and Efficacy of <scp>Long‐Term</scp> Voclosporin Treatment for Lupus Nephritis in the Phase 3 <scp>AURORA</scp> 2 Clinical Trial Amit Saxena, Ellen M. Ginzler, Keisha L. Gibson, Arthritis & Rheumatology	2023	90
The PROMISE Study: A Phase 2b Multicenter Study of Voclosporin (ISA247) Versus Tacrolimus in De Novo Kidney Transplantation Stéphan Busque, Marcelo Cantarovich, S. Mulgaonkar, American Journal of Transplantation Versus TacrolimusPromise StudyTransplantationKidney TransplantPhase 2B	2011	88
A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis Robert Bissonnette, Kim Papp, Yves Poulin, Journal of the American Academy of Dermatology Placebo-controlled Phase 2Clinical TrialsClinical DermatologyChronic Plaque PsoriasisDermatology	2006	56
Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus Nephritis Cristina Arriens, Y K Onno Teng, Ellen M. Ginzler, Arthritis Care & Research	2022	38
Differential Effects of Voclosporin and Tacrolimus on Insulin Secretion From Human Islets Jelena Kolic, Leanne Beet, Peter Overby, Endocrinology Exocytosis MachineryImmunologyImmune RegulationPancreas TransplantationInsulin Signaling	2020	33
Voclosporin: a novel calcineurin inhibitor with no impact on mycophenolic acid levels in patients with SLE Teun van Gelder, Robert B. Huizinga, Laura Lisk, Nephrology Dialysis Transplantation	2021	24
Cytochrome P450 3A and P-glycoprotein drug-drug interactions with voclosporin Spencer Ling, Robert B. Huizinga, Patrick Mayo, British Journal of Clinical Pharmacology	2013	21
ISA247: Quality of Life Results from a Phase II, Randomized, Placebo-Controlled Study Aditya K. Gupta, Richard G. Langley, Charles Lynde, Journal of Cutaneous Medicine and Surgery	2008	19

Page 1